Behavioral health and population health technology services
Strategic Profile
Gregory R. Alexander was appointed Chief Executive Officer effective January 5, 2026, bringing executive leadership experience. The company expects to achieve profitability by year-end 2026, driven by continued strong demand for its comprehensive population health solutions, disciplined cost management, and new contract wins. The company voluntarily delisted from Nasdaq in April 2025 to reduce costs and focus on strengthening core fundamentals.
Cyborg Score Rationale
The company operates at substantial disadvantage: ~$4.7M market cap, $7.2M trailing twelve-month revenue, and -$896K net loss. Stock delisting and depressed trading signal execution and market confidence challenges, though management expects profitability by end-2026.
Top Insights
Population Health revenue grew 197% in Q2 2025 to $1.6M, primarily driven by a $5.8M contract to train home and community-based services workers for Indiana Medicaid beneficiaries.
The company offers Syrenity (behavioral/mental health app), SyraBot (AI-powered chatbot), and CarePlus (EMR solution for small to mid-sized providers).
Delisted from Nasdaq in April 2025 after failing to maintain $1.00 minimum bid price; now trades on OTC.
Company targets full-year 2026 profitability through demand growth, cost discipline, and new government and private contracts.
Named Competitors
Behavioral Health Services — Large integrated healthcare and behavioral health services
Mental Health Platform — Digital mental and behavioral health solutions
Population Health Analytics — Healthcare data analytics and population health management
Healthcare Staffing — Healthcare workforce staffing and solutions
Recent Developments
(January 2026) Gregory R. Alexander appointed CEO effective January 5, 2026
(April 2025) Voluntary delisting from Nasdaq Capital Market; shifted to OTC trading
(Q2 2025) Population Health revenue surged 197% driven by $5.8M Indiana HCBS training contract